What is the risk of testicular atrophy in post‑pubertal males with mumps orchitis and how should it be managed?

Mumps Orchitis and Testicular Atrophy: Risk and Management

Risk of Testicular Atrophy

Testicular atrophy after mumps orchitis is a significant and common complication, occurring in approximately 30-50% of affected testes, with the highest risk in bilateral cases. 1, 2

• Mumps orchitis develops in up to 38% of postpubertal males infected with mumps virus 3
• Among affected testes, atrophy rates are substantial: one series documented atrophy in 7 of 9 affected testes (78%) 2, while ultrasonographic studies show atrophic testes averaging 44.7% smaller in volume than contralateral normal testes 1
• The time course from acute orchitis to detectable atrophy ranges from 25 to 230 days (mean 95.9 days) on follow-up imaging 1
• Bilateral orchitis occurs in 16-65% of mumps orchitis cases, substantially increasing sterility risk 4

Acute Management

Immediate Supportive Care

Provide acetaminophen or NSAIDs for pain and fever control, ensure adequate hydration with soft foods, and implement strict droplet isolation for 5 days after parotitis onset. 3, 5

• Pain management is critical as testicular inflammation causes severe discomfort 3
• Maintain hydration despite painful swallowing from concurrent parotitis 3
• Isolate patients immediately as they remain contagious from 7 days before through 8 days after parotitis onset 5

Consideration of Interferon Therapy

While not included in current CDC or AAP guidelines, interferon-alpha 2B therapy (3 × 10⁶ IU daily for 7 days) shows promise in preventing testicular atrophy and preserving fertility in small case series. 6, 4

• Two small studies from the early 1990s reported dramatic symptom improvement within 2-4 days and prevention of testicular atrophy during 6-15 months follow-up 6, 4
• Three of four patients with pre-treatment oligoasthenospermia achieved normospermia 2-4 months after interferon treatment 4
• Flu-like side effects can be mitigated with concomitant paracetamol 500 mg three times daily 4
• Important caveat: These are small, uncontrolled studies from 1991-1995; interferon therapy is not mentioned in current AAP or CDC guidelines 3, 5, suggesting limited adoption in standard practice

Corticosteroid Therapy

• Systemic corticosteroid therapy has been historically discussed for mumps orchitis, though evidence is limited 2
• Current guidelines reserve corticosteroids specifically for facial nerve palsy (prednisone 1-2 mg/kg/day for 5-7 days) 3, 5

Monitoring and Complications

Surveillance Strategy

Monitor closely for complications that are significantly more severe in adults than children, including progression to bilateral involvement, aseptic meningitis, encephalitis, and hearing loss. 3, 5

• Assess for contralateral testicular involvement, as bilateral disease dramatically increases sterility risk 4
• Watch for severe headache, neck stiffness, or altered mental status suggesting aseptic meningitis (4-6% of cases) 5
• Evaluate for sudden sensorineural hearing loss, which can be bilateral and permanent 5

Ultrasonographic Follow-Up

Perform follow-up testicular ultrasonography 3-6 months after acute orchitis to document testicular volume, echogenicity, and vascularity. 1

• Atrophic testes characteristically show an oblong shape, heterogeneous hypoechogenicity with multiple hyperechoic islands, and decreased vascularity on color Doppler 1
• Volume reduction averaging 44.7% compared to the contralateral testis indicates significant atrophy 1

Long-Term Fertility Counseling

Counsel patients that unilateral orchitis with atrophy typically preserves fertility if the contralateral testis is normal, but bilateral involvement carries substantial risk of permanent infertility. 4, 7

• Recommend semen analysis 3-6 months after acute illness to assess fertility potential 4, 7
• Discuss sperm banking before potential future mumps exposure in high-risk settings (outbreaks) for unvaccinated or under-vaccinated males 7
• Emphasize that even with unilateral atrophy, paternity rates can remain near normal if the contralateral testis is healthy 7

Prevention

Report all probable or confirmed mumps cases immediately to state and local health departments to enable outbreak control and contact vaccination. 3, 5

• Identify and vaccinate susceptible contacts immediately in outbreak settings 5
• Exclude susceptible individuals from affected settings until vaccinated or 26 days after onset of parotitis in the last case 5